AngioDynamics (ANGO) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.96 +1.17%
Revenue Growth %: +0.0%
Financial Fact:
General and administrative: 8.17M
Today's EPS Names:
CCEL, SLP, TMQ, More
Revenue Growth %: +0.0%
Financial Fact:
General and administrative: 8.17M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $66 million versus the consensus estimate of $75.73 million.
GUIDANCE:
AngioDynamics sees FY2024 EPS of ($0.54)-($0.58), versus the consensus of ($0.43). AngioDynamics sees FY2024 revenue of $270-275 million, versus the consensus of $312.1 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Simply Good Foods (SMPL) Tops Q3 EPS by 7c; offers outlook
- Citi upgrades Knight-Swift and Saia to Buy after trucking stock pullback
- Applied Materials surges as CEO signals multi-year chip boom
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
